Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Diclofenac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for diclofenac?

Diclofenac is the generic ingredient in fourteen branded drugs marketed by Iroko Pharms Llc, Inst Biochem, Depomed Inc, Teva, Sandoz, Novartis, Bionpharma Inc, Watson Labs, Apotex, Mylan, Par Form, Sun Pharm Inds, Apotex Inc, Glenmark Pharms Ltd, Dexcel Ltd, Fougera Pharms, Falcon Pharms, Actavis Elizabeth, Amneal Pharms, Taro, Glaxosmithkline Cons, Horizon Pharma, Sandoz Inc, Lupin Ltd, Pliva, Tolmar, Akorn, Nuvo Res Inc, Watson Labs Inc, Rising Pharms Inc, Teva Pharms, Unique Pharm Labs, Teligent Pharma Inc, Novel Labs Inc, Mylan Pharms Inc, Altaire Pharms Inc, Carlsbad, Nostrum Labs, Roxane, Bausch And Lomb, Vpna, Actavis Mid Atlantic, Paddock Llc, Javelin Pharms Inc, Gd Searle Llc, Eagle Pharms, and Actavis Labs Fl Inc, and is included in sixty-four NDAs. There are forty-two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has thirty-three patent family members in twenty countries.

There are forty-seven drug master file entries for diclofenac. One supplier is listed for this compound. There are five tentative approvals for this compound.

Summary for Generic Name: diclofenac

Tradenames:14
Patents:43
Applicants:47
NDAs:64
Drug Master File Entries: see list47
Suppliers / Packagers: see list1
Bulk Api Vendors: see list62
Clinical Trials: see list85
Patent Applications: see list20,278
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diclofenac at DailyMed

Pharmacology for Ingredient: diclofenac

Tentative approvals for DICLOFENAC

Applicant Application No. Form Dosage
► Subscribe► SubscribeSOLUTION;TOPICAL2%
► Subscribe► SubscribeSOLUTION;TOPICAL2%
► Subscribe► SubscribeSOLUTION;TOPICAL2%
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Depomed Inc
CAMBIA
diclofenac potassium
FOR SOLUTION;ORAL022165-001Jun 17, 2009RXYesYes6,974,595► Subscribe ► Subscribe
Javelin Pharms Inc
DYLOJECT
diclofenac sodium
SOLUTION;INTRAVENOUS022396-001Dec 23, 2014RXYesYes8,946,292► Subscribe ► Subscribe
Horizon Pharma
PENNSAID
diclofenac sodium
SOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes8,618,164► Subscribe ► Subscribe
Sandoz
DICLOFENAC SODIUM
diclofenac sodium
TABLET, DELAYED RELEASE;ORAL074376-001Sep 28, 1995RXNoYes► Subscribe► Subscribe
Novartis
VOLTAREN
diclofenac sodium
SOLUTION/DROPS;OPHTHALMIC020037-001Mar 28, 1991RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: diclofenac

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,735,450Formulation of diclofenac► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: diclofenac

Country Document Number Estimated Expiration
Philippines12015500301► Subscribe
Ukraine106232► Subscribe
New Zealand620887► Subscribe
African Regional IP Organization (ARIPO)201508933► Subscribe
China102438610► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc